CFDE Data Portal | Search KRT8P47

	Label	Description
	KRT8P47 associations Collection (Entity type)	Associations for KRT8P47_associations
	KRT8P47 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	KRT8P47 Gene (Entity type)	ENSG00000271647 - keratin 8 pseudogene 47
	GSE193838 catechin 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE173116 GSE173118 ML-7 3 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE222758 clofazimine U2OS 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE151090 verteporfin 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE151090 verteporfin 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	TAS2R43 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE171845 CCNE1 overexpression 4 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

KRT8P47 associations

Associations for KRT8P47_associations

KRT8P47 associations.tsv

A file from IDG as part of the Harmonizome project

KRT8P47

ENSG00000271647 - keratin 8 pseudogene 47

GSE193838 catechin 0 v 2 human dn

A Gene Set from LINCS

GSE173116 GSE173118 ML-7 3 v 10 human up

A Gene Set from LINCS

GSE222758 clofazimine U2OS 0 v 2 human up

A Gene Set from LINCS

GSE151090 verteporfin 0 v 3 human dn

A Gene Set from LINCS

GSE151090 verteporfin 2 v 3 human dn

A Gene Set from LINCS

TAS2R43 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GSE171845 CCNE1 overexpression 4 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.